Because SOCS3 has been proposed as a mechanism of IL-10–mediated protection against inflammatory processes in other models of lung disease (Gao and Ward 2007), we asked whether SOCS3 was differentially expressed in Il10−/− and Il10+/+ mice. Here, SOCS3 is linked to lung disorder.